R. Duarte (Porto, Portugal), S. Tiberi (London, United Kingdom)
High-dose rifampicin in tuberculosis: experiences from a Dutch tuberculosis centre C. Seijger (Nijmegen, Netherlands), W. Hoefsloot (Nijmegen, Netherlands), I. Bergsma (Nijmegen, Netherlands), J. Van Ingen (Nijmegen, Netherlands), S. Kuijpers (Nijmegen, Netherlands), L. Te Brake (Nijmegen, Netherlands), R. Van Crevel (Nijmegen, Netherlands), R. Aarnoutse (Nijmegen, Netherlands), M. Boeree (Nijmegen, Netherlands), C. Magis-Escurra (Nijmegen, Netherlands)
|    |
Comorbidity clusters associated with length of hospital stay in patients with tuberculosis F. Baty (St. Gallen, Switzerland), O. Schoch (St. Gallen, Switzerland), S. Tonko (St. Gallen, Switzerland), M. Brutsche (St. Gallen, Switzerland)
|    |
Results of traditional and new regimens of MDR/XDR TB treatment: cohort analysis S. Borisov (Moscow, Russian Federation), A. Filippov (Moscow, Russian Federation), I. Danilova (Moscow, Russian Federation), S. Kosenkov (Moscow, Russian Federation)
|    |
Drug resistance-conferring mutations in Mycobacterium-tuberculosis isolated from retreated patients in Hanoi, Vietnam N. Thi Le Hang (Hanoi, Vietnam), M. Hijikata (Tokyo, Japan), S. Maeda (Hokkaido, Japan), P. Huu Thuong (Hanoi, Vietnam), H. Van Huan (Hanoi, Vietnam), N. Phuong Hoang (Hanoi, Vietnam), I. Matsushita (Tokyo, Japan), N. Keicho (Tokyo, Japan)
|    |
Bedaquiline containing regimens for the treatment of multi- and extensively drug-resistant tuberculosis at the programmatic level in Belarus. Prospective cohort study. A. Skrahina (Minsk, Belarus), H. Hurevich (Minsk, Belarus), S. Setkina (Minsk, Belarus), V. Grankov (Minsk, Belarus), V. Solodovnikova (Minsk, Belarus), D. Viatushka (Minsk, Belarus), V. Kralko (Minsk, Belarus), D. Klimuk (Minsk, Belarus), M. Dara (Copenhagen, Denmark)
|    |
Characteristics of drug susceptibility testing for bedaquline and clofazimine of 178 drug-resistant Mycobacterium tuberculosis isolates in Japan A. Takaki (Tokyo, Japan), A. Aono (Tokyo, Japan), K. Chikamatsu (Tokyo, Japan), Y. Igarashi (Tokyo, Japan), Y. Shimomura (Tokyo, Japan), Y. Murase (Tokyo, Japan), H. Yoshida (Osaka, Japan), . Tamura (Osaka, Japan), T. Nagai (Osaka, Japan), Y. Morishige (Tokyo, Japan), H. Yamada (Tokyo, Japan), S. Mitarai (Tokyo, Japan)
|    |
Tobacco smoking as a risk factor of active tuberculosis in HIV-infected patients E. Kulabukhova (Moscow, Russian Federation), V. Zimina (Moscow, Russian Federation), A. Kravtchenko (Moscow, Russian Federation), S. Degtyareva (Moscow, Russian Federation), E. Beloborodova (Moscow, Russian Federation), A. Peregudova (Moscow, Russian Federation)
|     |